1. Home
  2. RCKT vs IIIV Comparison

RCKT vs IIIV Comparison

Compare RCKT & IIIV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Rocket Pharmaceuticals Inc.

RCKT

Rocket Pharmaceuticals Inc.

HOLD

Current Price

$3.91

Market Cap

401.6M

Sector

Health Care

ML Signal

HOLD

Logo i3 Verticals Inc.

IIIV

i3 Verticals Inc.

HOLD

Current Price

$21.03

Market Cap

434.2M

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
RCKT
IIIV
Founded
1999
2012
Country
United States
United States
Employees
202
N/A
Industry
Biotechnology: Pharmaceutical Preparations
EDP Services
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
401.6M
434.2M
IPO Year
N/A
2018

Fundamental Metrics

Financial Performance
Metric
RCKT
IIIV
Price
$3.91
$21.03
Analyst Decision
Buy
Strong Buy
Analyst Count
14
5
Target Price
$29.73
$33.20
AVG Volume (30 Days)
3.2M
478.7K
Earning Date
05-04-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
0.08
Revenue
N/A
N/A
Revenue This Year
N/A
$9.05
Revenue Next Year
$64.28
$8.07
P/E Ratio
N/A
$262.38
Revenue Growth
N/A
N/A
52 Week Low
$2.53
$18.47
52 Week High
$5.45
$33.97

Technical Indicators

Market Signals
Indicator
RCKT
IIIV
Relative Strength Index (RSI) 64.16 52.52
Support Level $3.01 $19.11
Resistance Level $4.04 $21.27
Average True Range (ATR) 0.26 0.98
MACD 0.09 0.03
Stochastic Oscillator 69.32 41.69

Price Performance

Historical Comparison
RCKT
IIIV

About RCKT Rocket Pharmaceuticals Inc.

Rocket Pharmaceuticals Inc is a late-stage biopharmaceutical company. It is focused on the development of gene therapies for rare and devastating pediatric diseases. The pipeline products of the company include RP-A501 for Danaon Disease, RP-L102 for Fanconi Anemia, RP-L201 for Leukocyte Adhesion, RP-L301 for Pyruvate Kinase Deficiency, and RP-L401 for Infantile Malignant Osteopetrosis. It has one reportable segment related to R&D and commercial readiness of its gene therapies.

About IIIV i3 Verticals Inc.

i3 Verticals Inc provides mission-critical enterprise software solutions to public sector entities. These comprehensive cloud-native solutions address a broad range of government functions, including courts and public safety, public administration, utilities, transportation and schools. The company generates the majority of revenue from software and related services, including the sale of subscriptions, recurring services, ongoing support, licenses, and installation and implementation services specific to software.

Share on Social Networks: